Application Value of Iodine-131 Combined with Levothyroxine Sodium in Patients with Differentiated Thyroid Cancer after Surgery
Oncology · 2024
DOI: 10.1159/000541546 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Oncology, 2024. Verfasst von Jinmiao Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thyroid Surgery, Tianjin Union Medical Center, Nankai University, Tianjin, China. Hauptthemen laut MEDLINE: Iodine Radioisotopes, Thyroid Neoplasms, Thyroxine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Introduction
This study aimed to evaluate the clinical value of iodine-131 combined with levothyroxine sodium in the treatment of patients with differentiated thyroid cancer (DTC) after surgery.
Methods
Prospective randomized controlled studies were conducted. A total of 374 DTC patients who underwent total or near-total thyroidectomy in the Department of Thyroid Surgery, Tianjin Union Medical Center and Tianjin Medical University General Hospital, from January 2019 to February 2022 were selected and divided into control group (187 cases) and observation group (187 cases) according to random number table method. The control group was treated with levothyroxine sodium after surgery, and the observation group was treated with iodine-131 on the basis of the control group. Gender, age, course of disease, tumor diameter, pathological type, TNM classification, treatment effect, thyroglobulin (Tg) levels before and after treatment, SF-36 health status questionnaires (SF-36), occurrence of adverse reactions after treatment, and recurrence rate of 1-year follow-up were compared and analyzed between the two groups.
Results
There was no significant difference in baseline data between the two groups. After treatment, the effective rate of the observation group increased by 11.23% compared to the control group, with a statistically significant difference (91.98% vs. 80.75%, p < 0.05). There was no significant difference in Tg level and scores of SF-36 evaluation including physical functioning, physical problems, vitality, pain, mental health, emotional problems, social functioning, and general health perception between the two groups before surgery (p > 0.05), Tg levels and scores of SF-36 evaluation in all dimensions were significantly improved in both groups after treatment (p < 0.05), and the levels of Tg and scores of SF-36 in all dimensions in observation group were significantly better than those in control group after treatment (p < 0.001). There was no significant difference in the incidence of adverse reactions between the two groups (p > 0.05). The recurrence rate in the observation group was 5.89% lower than that in the control group 1 year after treatment, with a statistically significant difference (2.67% vs. 8.56%, p < 0.05).
Conclusions
The combination of iodine-131 and levothyroxine sodium in the postoperative treatment of DTC can improve the therapeutic effect and reduce the postoperative recurrence rate without increasing adverse reactions, which is worthy of clinical reference and promotion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thyroid Surgery, Tianjin Union Medical Center, Nankai University, Tianjin, China.
- Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China.
Zitieren
APA
Wang, J., Hao, J., Gao, Y., Wang, S., Wang, D., Tao, W., Duan, R., Zhang, Z., & Gao, M. (2024). Application Value of Iodine-131 Combined with Levothyroxine Sodium in Patients with Differentiated Thyroid Cancer after Surgery. Oncology. https://doi.org/10.1159/000541546
Vancouver
Wang J, Hao J, Gao Y, Wang S, Wang D, Tao W, et al. Application Value of Iodine-131 Combined with Levothyroxine Sodium in Patients with Differentiated Thyroid Cancer after Surgery. Oncology. 2024. doi:10.1159/000541546
BibTeX
@article{Wang2024,
author = {Wang, Jinmiao and Hao, Jie and Gao, Ying and Wang, Shoujun and Wang, Duowei and Tao, Weijie and Duan, Ran and Zhang, Zhendong and Gao, Ming},
title = {Application Value of Iodine-131 Combined with Levothyroxine Sodium in Patients with Differentiated Thyroid Cancer after Surgery},
journal = {Oncology},
year = {2024},
doi = {10.1159/000541546}
}
EUVIMED